Cathay Biotech Inc. (SHA: 688065)
China
· Delayed Price · Currency is CNY 34.28
-0.98 (-2.78%)
Sep 6, 2024, 3:00 PM CST
Cathay Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Net Income | 372.11 | 366.52 | 553.27 | 594.72 | 457.67 | 478.88 | Upgrade
|
| Depreciation & Amortization | 302.64 | 280.95 | 265.12 | 168.54 | 118.32 | 116.27 | Upgrade
|
| Other Amortization | 11.52 | 8.65 | 4.68 | 3.68 | 2.27 | 1.39 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.01 | 0.01 | -0.05 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 22.97 | 27.65 | 36.22 | 10.69 | 12.93 | -6.28 | Upgrade
|
| Loss (Gain) From Sale of Investments | 7.83 | 7.82 | 3.71 | -16.3 | -27.97 | -13.46 | Upgrade
|
| Other Operating Activities | 87.77 | 47.9 | -3.57 | 25.36 | 24.35 | 4.71 | Upgrade
|
| Change in Accounts Receivable | -319.83 | -320.06 | 24.8 | -224.95 | -25.54 | 232.28 | Upgrade
|
| Change in Inventory | 123.41 | 78.3 | -418.06 | -282.62 | -90.45 | -434.03 | Upgrade
|
| Change in Accounts Payable | 136.17 | 133.66 | 355.46 | 310.02 | 33.28 | -7.35 | Upgrade
|
| Change in Other Net Operating Assets | 3.91 | 8.65 | 18.18 | 6.47 | 5.35 | 4.77 | Upgrade
|
| Operating Cash Flow | 680.74 | 569.45 | 803.67 | 578.69 | 514.96 | 359.62 | Upgrade
|
| Operating Cash Flow Growth | -11.18% | -29.14% | 38.88% | 12.37% | 43.20% | - | Upgrade
|
| Capital Expenditures | -1,366 | -1,570 | -4,198 | -1,459 | -763.11 | -511.14 | Upgrade
|
| Sale of Property, Plant & Equipment | 142.01 | 142.01 | 0.14 | - | - | 2.51 | Upgrade
|
| Investment in Securities | - | -101.04 | - | 1,320 | -470 | -787.1 | Upgrade
|
| Other Investing Activities | - | -30 | - | 28.42 | 35.88 | 9.1 | Upgrade
|
| Investing Cash Flow | -1,224 | -1,559 | -4,198 | -110.76 | -1,197 | -1,207 | Upgrade
|
| Long-Term Debt Issued | - | 937.02 | 1,126 | 798.08 | - | 562.25 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -300.24 | - | Upgrade
|
| Long-Term Debt Repaid | - | -289.77 | -740 | -55 | - | -390.48 | Upgrade
|
| Total Debt Repaid | -1,843 | -289.77 | -740 | -55 | -300.24 | -390.48 | Upgrade
|
| Net Debt Issued (Repaid) | -145.97 | 647.25 | 386.47 | 743.08 | -300.24 | 171.77 | Upgrade
|
| Issuance of Common Stock | 4.17 | 4.17 | 4.52 | - | 6,661 | 1,000 | Upgrade
|
| Repurchase of Common Stock | -49.45 | -31.52 | -94.67 | - | - | - | Upgrade
|
| Common Dividends Paid | -139.73 | -137.75 | -206.85 | -339.63 | -3.87 | -121.34 | Upgrade
|
| Dividends Paid | -139.73 | -137.75 | -206.85 | -339.63 | -3.87 | -121.34 | Upgrade
|
| Other Financing Activities | -400.98 | -744.31 | 314.41 | 2,584 | -293.06 | - | Upgrade
|
| Financing Cash Flow | -731.96 | -262.16 | 403.88 | 2,987 | 6,063 | 1,050 | Upgrade
|
| Foreign Exchange Rate Adjustments | -5.77 | 40.22 | 59.98 | -9.19 | -2.83 | -1.32 | Upgrade
|
| Net Cash Flow | -1,281 | -1,211 | -2,931 | 3,446 | 5,378 | 202 | Upgrade
|
| Free Cash Flow | -685.6 | -1,000 | -3,395 | -880.49 | -248.15 | -151.52 | Upgrade
|
| Free Cash Flow Margin | -27.12% | -47.32% | -139.06% | -37.25% | -16.57% | -7.91% | Upgrade
|
| Free Cash Flow Per Share | -1.18 | -1.72 | -5.83 | -1.51 | -0.46 | -0.30 | Upgrade
|
| Cash Income Tax Paid | 197.14 | 90.88 | -281.56 | -12.97 | 36 | 199.15 | Upgrade
|
| Levered Free Cash Flow | -566.74 | -567.98 | -3,302 | -1,301 | -673.57 | -609.31 | Upgrade
|
| Unlevered Free Cash Flow | -547.38 | -547.87 | -3,290 | -1,290 | -671.16 | -598.67 | Upgrade
|
| Change in Net Working Capital | -350.16 | -622.24 | -368.28 | 321.72 | 308.6 | 540.29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.